Investor-only Dinner

For 2012, this invitation-only dinner will be held at a new location offering excellent wine and fine dining. The dinner will give up to 80 life science investors the chance to get together in an exclusive environment, and is the largest meeting of its kind in Europe.

The dinner will give investors the chance to get together and network in an exclusive environment ready for the first day of the BioTrinity Conference.

A select group of qualified active life science investors have been invited to attend the BioTrinity Investor-Only Dinner, a gathering that one invitee has referred to as the BioTrinity international "VC Hall of Fame". This dinner provides a forum for closer working relationships to be developed and to encourage co-participation on future investment rounds in the UK life science sector on the eve of UK’s premier biopartnering and investment conference. Acceptance of the invitation to attend this exclusive dinner includes registration and attendance at BioTrinity conference.

2011 Investor-only Dinner was Sponsored by:

	Abingworth
	Alacrita
	Imperial Innovation
	Oxford Capital Partners

The 2012 Menu

Champagne reception and canapés
Laurent Perrier Champagne, France

Cauliflower velouté with truffle oil and chives

Duck parcel, spring vegetables with beetroot and ginger juice (in a shot glass)
Stirling Rocks Semillon Sauvignon, Australia
Sancerre Domain Gerard Millet, France

Sea bass, olive crushed baby potatoes and vanilla sauce
Berton Reserve Chardonnay, Australia
Pouilly Fuisse Domaine Ferrand, France

Pink loin of venison, roasted roots and wild blackberries
Leabrook Estate Pinot Noir, Australia
Givry 1er Cru 'Clos de la Servoisine' Domaine Joblot, France

Chocolate panna cotta, rhubarb compote
Berton Reserve Botrytis Semillon, Australia
Castelnau de Suduiraut, Sauternes, France

Selection of regional cheese served with rich fruit loaf and chutney
Starboard 88 (available on request)

Coffee with a chocolate orange truffle

Who booked to attend in 2011:

Here is list of the investment firms who attended the dinner in 2011:

• Abingworth LLP
• Advent Venture Partners
• Aelios Finance (France)
• Aescap Venture (Netherlands)
• Albion Ventures
• Amadeus Capital Partner
• Apposite Capital LLP
• Aquarius Equity Partners
• BioScience Managers Limited
• Boehringer Ingelheim Venture Fund
• Clubb Capital
• Collins Stewart Europe
• Delta Partners
• DFJ Esprit LLP
• ECI Partners
• Edison Investment Research
• Edmond de Rothschild Investment Partners
• Entrepreneurs Fund Management LLP
• ETV Capital Limited
• Excalibur Group Holdings Ltd
• Finance Wales
• Forbion Capital Partners (Netherlands)
• Fosun Pharma (UK)
• Fountain Healthcare Partners (Ireland)
• Genetrix SL (Spain)
• Imperial Innovations
• Inventages Venture Capital
• IP Group Plc
• IQ Capital Partners LLP
• LD Invest Life Science Capital
• Lundbeckfond Ventures
• Matrix Group Investment Banking Division
• Mercia Fund Management
• Merck Serono Ventures (Switzerland)
• Midven
• Morningside (China / US)
• MP Healthcare Venture Management
• MVM Life Science Partners LLP
• NeoMed
• New Hill Management (US)
• Novo A/S (Denmark)
• Numis Securities
• Oxford Capital Partners
• Oxford Technology Management
• Peel Hunt
• Phase4 Ventures
• Rainbow Seed Fund
• Royal Society Enterprise Fund
• Scottish Equity Partners
• Seroba Kernel Life Sciences (Ireland)
• Seventure Partners (France)
• Shire Strategic Investment Group
• Singer Capital Markets
• Sofinnova Partners
• SPARK Ventures
• SR One
• Sudbrook Associates LLP
• Sultan Scientific
• Synergis Technologies
• Technikos LLP
• Versant EuroVentures (Switzerland)

2010 investors:

Abingworth
Advent Venture Partners    
Andy Richards
Atlas Venture   
Beringea
Canaccord Adams   
Edmond de Rothschild Investment Partners (France)   
Entrepreneurs Fund    
Esperante Ventures (Netherlands)   
ETV Capital    
Excalibur (formerly Merlin Biosciences)   
Forbion Capital Partners    
Genzyme Ventures (US)    
H20 Venture Partners   
IP Group plc    
Ipso Ventures    
IQ Capital   
London Technology Fund    
Louis Nisbet   
Mercia Technology Seed Fund    
MVM Life Science Partners   
NGN Capital   
Nomura Code Securities   
Novo A/S (Denmark)   
Orion Healthcare Equity Partners (US)    
Oxford Capital Partners    
Oxford Technology Management   
Rainbow Seed Fund   
Rosetta Capital    
Seraphim Capital    
Sofinnova Ventures   
SPARK Ventures    
SR One   
TRI Inc. (US)